Chandan Healthcare share price
NSE: CHANDANHealthcare Services
Chandan Healthcare Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2025 · Issue price ₹159
Last close ₹224.20down ₹3.00 (1.32%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹227.20.
28 Oct: open ₹224.00, high ₹224.50, low ₹224.00
52-week range of traded prices to 28 Oct 2026
₹185.40Low, 19 Jun 2026₹358.00High, 18 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹576 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,200
Results
Consolidated; ₹ crore.Chandan Healthcare quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹81 Crup 6.97%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹7.50 Crup 8.34%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 9.3%
Revenue by quarter
Peak revenue ₹81 Cr, quarter to Jun 2026; lowest ₹65 Cr, quarter to Dec 2025
Net profit by quarter, a loss in red
| ₹ crore | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Revenue | 65.0 | 75.6 | 80.9 |
| Net profit | 4.5 | 6.9 | 7.5 |
| Net margin | 7.0% | 9.2% | 9.3% |
Consolidated. The 3 quarters from Dec 2025, the first on record; the half years before them are below. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
| ₹ crore | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 110 | 120 | 136 |
| Net profit | 11 | 12 | 16 |
| Net margin | 9.6% | 9.6% | 11.5% |
Consolidated. The half years in the same span that the quarters on record do not fully cover.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹276 Crup 20.11%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹27 Crup 22.04%
- Net margin
- 9.8%
Revenue by year
Peak revenue ₹276 Cr, year to Mar 2026; lowest ₹230 Cr, year to Mar 2025
Net profit by year, a loss in red
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 230 | 276 |
| Net profit | 22 | 27 |
| Net margin | 9.6% | 9.8% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare Sector, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +21.2% | +22.0% | −0.7% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Chandan Healthcare insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group1 purchase, 0 sales₹0.22 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.22 Cr
- Others0 purchases, 1 saleNo purchase₹0.10 CrNet−₹0.10 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Chandan Healthcare competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Chandan Healthcare in market cap.Healthcare companies
Chandan Healthcare is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 One Global Service ProviderONEGLOBAL | 918 | 12.41 | 6.50 | +161.6% | +178.3% | 69.4% | 69.2% | 0.21% |
 Health X PlatformHEALTHX | 887 | – | 1.38 | +28.8% | – | −3.1% | −9.4% | 0.00% |
 Gaudium IVF and Women HealthGAUDIUMIVF | 717 | – | 4.71 | – | – | – | – | 0.00% |
| Credent Connect N CareCREDENT | 635 | – | – | – | – | – | – | 0.00% |
| Pramodini MedicarePRAMODINI | 240 | – | – | – | – | – | – | 0.00% |
 Choksi LaboratoriesCHOKSILA | 149 | 68.94 | 5.83 | +10.7% | +45.3% | 8.8% | 9.2% | 0.00% |
 Star Imaging and Path LabSTARIMAGIN | 130 | 6.75 | 1.12 | – | – | 16.6% | – | 0.00% |
 Aspira Pathlab & DiagnosticsASPIRA | 129 | – | 10.57 | +14.6% | −117.7% | −3.7% | −4.4% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Chandan Healthcare announcements
Oct 2026
13 Oct
7 Oct
6 Oct
6 Oct · Management
6 Oct
Chandan Healthcare share price by year
Each calendar year to 2025.Chandan Healthcare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 324.55 | – | 347.20 | 149.70 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 17 Feb 2025.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 234.00 | 234.90 | 225.05 | 227.20 | 229.95 | 8,800 | 63.6% |
| 26 Oct 2026 | 219.00 | 227.90 | 219.00 | 227.90 | 223.21 | 3,200 | 75.0% |
| 23 Oct 2026 | 234.95 | 235.00 | 213.75 | 218.60 | 220.57 | 36,000 | 62.2% |
| 22 Oct 2026 | 229.00 | 229.00 | 228.00 | 229.00 | 228.67 | 2,400 | 100.0% |
| 21 Oct 2026 | 229.00 | 229.55 | 226.00 | 229.00 | 227.56 | 8,000 | 100.0% |
| 19 Oct 2026 | 236.00 | 236.00 | 227.50 | 228.50 | 231.91 | 28,800 | 66.7% |
| 16 Oct 2026 | 240.00 | 244.00 | 236.05 | 238.40 | 240.23 | 20,800 | 57.7% |
| 15 Oct 2026 | 240.00 | 249.90 | 240.00 | 240.65 | 243.95 | 17,600 | 72.7% |
| 14 Oct 2026 | 235.00 | 238.00 | 233.00 | 237.85 | 235.73 | 15,200 | 79.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- CHANDAN
- ISIN
- INE0B2N01016
- Industry
- Healthcare Services